Natera, Inc. - stock earnings
NTRA Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 AfterMarket | - / -0.7208000000 | - | - / 322.6 million | - |
NTRA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -78.0 million USD | 311.1 million USD |
| 2023Q3 | -109.0 million USD | 268.3 million USD |
| 2023Q2 | -110.8 million USD | 261.4 million USD |
| 2023Q1 | -136.9 million USD | 241.8 million USD |
| 2022Q4 | -142.6 million USD | 217.3 million USD |
| 2022Q3 | -121.5 million USD | 210.6 million USD |
| 2022Q2 | -145.2 million USD | 198.2 million USD |
| 2022Q1 | -138.6 million USD | 194.1 million USD |
| 2021Q4 | -140.6 million USD | 173.0 million USD |
| 2021Q3 | -151.3 million USD | 158.1 million USD |
| 2021Q2 | -116.0 million USD | 142.0 million USD |
| 2021Q1 | -63.9 million USD | 152.3 million USD |
| 2020Q4 | -76.4 million USD | 112.4 million USD |
| 2020Q3 | -58.3 million USD | 98.1 million USD |
| 2020Q2 | -59.6 million USD | 86.5 million USD |
| 2020Q1 | -35.4 million USD | 94.0 million USD |
| 2019Q4 | -35.2 million USD | 83.2 million USD |
| 2019Q3 | -23.1 million USD | 77.9 million USD |
| 2019Q2 | -32.4 million USD | 74.4 million USD |
| 2019Q1 | -34.1 million USD | 66.8 million USD |
| 2018Q4 | -31.8 million USD | 67.0 million USD |
| 2018Q3 | -29.6 million USD | 65.3 million USD |
| 2018Q2 | -33.8 million USD | 63.1 million USD |
| 2018Q1 | -32.9 million USD | 62.3 million USD |
| 2017Q4 | -45.5 million USD | 53.8 million USD |
| 2017Q3 | -27.1 million USD | 56.7 million USD |
| 2017Q2 | -27.7 million USD | 53.6 million USD |
| 2017Q1 | -36.0 million USD | 46.9 million USD |
| 2016Q4 | -37.9 million USD | 49.3 million USD |
| 2016Q3 | -26.0 million USD | 53.9 million USD |
| 2016Q2 | -23.2 million USD | 52.0 million USD |
| 2016Q1 | -8.7 million USD | 61.9 million USD |
| 2015Q4 | -23.0 million USD | 52.9 million USD |
| 2015Q3 | -17.6 million USD | 44.9 million USD |
| 2015Q2 | -19.7 million USD | 45.1 million USD |
| 2015Q1 | -10.0 million USD | 47.4 million USD |
| 2014Q4 | 1.3 million USD | 49.9 million USD |
| 2014Q3 | 3.7 million USD | 46.3 million USD |
| 2014Q2 | -514000 USD | 35.8 million USD |
| 2014Q1 | -9.6 million USD | 27.3 million USD |
| 2013Q4 | ? USD | 23.2 million USD |
| 2013Q3 | ? USD | 16.2 million USD |
| 2013Q2 | ? USD | 11.1 million USD |
| 2013Q1 | ? USD | 4.6 million USD |
NTRA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -434.8 million USD | 1.1 billion USD |
| 2022 | -547.8 million USD | 820.2 million USD |
| 2021 | -471.7 million USD | 625.5 million USD |
| 2020 | -229.7 million USD | 391.0 million USD |
| 2019 | -124.8 million USD | 302.3 million USD |
| 2018 | -128.2 million USD | 257.7 million USD |
| 2017 | -136.3 million USD | 210.9 million USD |
| 2016 | -95.8 million USD | 217.1 million USD |
| 2015 | -70.3 million USD | 190.4 million USD |
| 2014 | -5.2 million USD | 159.3 million USD |
| 2013 | -37.1 million USD | 55.2 million USD |
NTRA
Price: $95.71
52 week price:
Earnings Per Share: -3.78 USD
P/E Ratio: -15.59
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 659200
Ebitda: -23.3 millionMarket Capitalization: 11.4 billion